Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures

[1]  P. Wilson.  Cardiorespiratory Fitness Among Individuals With Psoriasis in the General Population. , 2016, Journal of physical activity & health.

[2]  A. Burden,et al.  Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis , 2016, The Journal of investigative dermatology.

[3]  M. Lebwohl,et al.  Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). , 2015, JAMA dermatology.

[4]  Mark Lunt,et al.  Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink. , 2015, The Journal of investigative dermatology.

[5]  N. Golden,et al.  Bone Health in Adolescence. , 2015, Adolescent medicine: state of the art reviews.

[6]  J. Varga,et al.  Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis , 2015, The Journal of dermatology.

[7]  Yao Gong,et al.  Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases. , 2015, Clinical and experimental rheumatology.

[8]  E. Edson-Heredia,et al.  Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  J. Soung,et al.  The role of vitamin D in psoriasis: a review , 2015, International journal of dermatology.

[10]  J. Silverberg.  Racial and Ethnic Disparities in Atopic Dermatitis , 2015, Current Dermatology Reports.

[11]  Deborah D Ingram,et al.  2013 NCHS Urban-Rural Classification Scheme for Counties. , 2014, Vital and health statistics. Series 2, Data evaluation and methods research.

[12]  J. Nolla,et al.  Bone mineral density status and frequency of osteoporosis and clinical fractures in 155 patients with psoriatic arthritis followed in a university hospital. , 2014, Reumatologia clinica.

[13]  A. Armstrong,et al.  Psoriasis prevalence among adults in the United States. , 2014, Journal of the American Academy of Dermatology.

[14]  A. Armstrong,et al.  Psoriasis and smoking: a systematic review and meta‐analysis , 2014, The British journal of dermatology.

[15]  J. Kremer,et al.  Proceedings of the 5th annual perspectives in rheumatic diseases. , 2013, Seminars in arthritis and rheumatism.

[16]  L. Herrinton,et al.  Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009 , 2013, Pharmacoepidemiology and drug safety.

[17]  L. Misery,et al.  Alcohol consumption and psoriasis: a systematic literature review , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  J. Nolla,et al.  Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures , 2013, Clinical Rheumatology.

[19]  M. Napolitano,et al.  Psoriasis and osteoporosis: data from a Southern Italian population , 2012, Archives of Osteoporosis.

[20]  Patrick B. Wilson,et al.  Psoriasis and physical activity: a review , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[21]  S. Grazio,et al.  Osteoporosis in psoriatic arthritis: Is there any? , 2011, Wiener klinische Wochenschrift.

[22]  M. Pinheiro,et al.  Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis , 2011, Arthritis Research & Therapy.

[23]  S. Fathi,et al.  Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity , 2011, International journal of dermatology.

[24]  A. Menter,et al.  Comorbidities in psoriasis patients. , 2010, Seminars in cutaneous medicine and surgery.

[25]  Eve Donnelly,et al.  The assessment of fracture risk. , 2010, The Journal of bone and joint surgery. American volume.

[26]  S. Gabriel,et al.  Potential misclassification of patients with psoriasis in electronic databases. , 2008, Journal of American Academy of Dermatology.

[27]  M. Bala,et al.  Psoriasis: cardiovascular risk factors and other disease comorbidities. , 2008, Journal of drugs in dermatology : JDD.

[28]  Niklas Zethraeus,et al.  Assessment of fracture risk , 2005, Osteoporosis International.

[29]  A. Evans,et al.  Bone mineral density of patients with chronic plaque psoriasis , 2001, Clinical and experimental dermatology.

[30]  J. Eisman,et al.  Mortality after all major types of osteoporotic fracture in men and women: an observational study , 1999, The Lancet.

[31]  J. Eisman,et al.  Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. , 1993, The New England journal of medicine.

[32]  K. Yamada.  [Systemic effects of topical corticosteroid treatment]. , 1972, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology.

[33]  R. Gebhardt,et al.  [Studies on the systemic effect of extensively applied topical steroids]. , 1972, Arztliche Forschung.

[34]  J. Griffith,et al.  Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors , 2014, Osteoporosis International.

[35]  M. Koršić,et al.  Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations. , 2006, Medical hypotheses.

[36]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .